Regulus Therapeutics Inc. Business Finance Contracts & Agreements

39 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement, dated March 11, 2024, by and among the Company and the Purchasers
Purchase Agreements
Regulus Therapeutics Inc.
Biotechnology
NY
2024
Amendment to Loan and Security Agreement, dated June 19, 2023, by and between the Registrant and Oxford Finance, LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2023
Description of Common Stock
Stock Agreements
Regulus Therapeutics Inc.
Biotechnology
2023
Regulus Therapeutics Inc. 2022 Employee Stock Purchase Plan
Stock Agreements
Regulus Therapeutics Inc.
Biotechnology
2022
Form of Common Stock Certificate of the Registrant
Stock Agreements
Regulus Therapeutics Inc.
Biotechnology
2022
Tenth Amendment to Loan and Security Agreement, dated August 25, 2020, by and among the Registrant and Oxford Finance, LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2022
Description of Common Stock
Stock Agreements
Regulus Therapeutics Inc.
Biotechnology
2022
Eleventh Amendment to Loan and Security Agreement, dated December 31, 2021, by and between the Company and Oxford Finance LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2022
Second Amendment to Loan and Security Agreement, dated March 6, 2018, by and between the Registrant and Oxford Finance LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2021
Securities Purchase Agreement, dated December 1, 2020, by and among the Company and the Purchasers
Purchase Agreements
Regulus Therapeutics Inc.
Biotechnology
NY
2020
Form of Common Stock Purchase Warrant
Warrant Agreements
Regulus Therapeutics Inc.
Biotechnology
2020
Tenth Amendment to Loan and Security Agreement, dated August 25, 2020, by and between the Registrant and Oxford Finance, LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2020
Ninth Amendment to Loan and Security Agreement, dated May 1, 2020, by and between the Registrant and Oxford Finance, LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2020
Description of Common Stock
Stock Agreements
Regulus Therapeutics Inc.
Biotechnology
2020
Seventh Amendment to Loan and Security Agreement, dated April 9, 2019, by and between the Registrant and Oxford Finance LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2019
Eighth Amendment to Loan and Security Agreement, dated May 3, 2019, by and between the Company and Oxford Finance LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2019
Securities Purchase Agreement, dated May 3, 2019, by and among the Company and the Purchasers
Purchase Agreements
Regulus Therapeutics Inc.
Biotechnology
NY
2019
Form of Common Stock Purchase Warrant
Warrant Agreements
Regulus Therapeutics Inc.
Biotechnology
2019
Sixth Amendment to Loan and Security Agreement, dated March 7, 2019, by and between the Registrant and Oxford Finance LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2019
Fourth Amendment to Loan and Security Agreement, dated November 5, 2018, by and between the Registrant and Oxford Finance LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2019
Fifth Amendment to Loan and Security Agreement, dated January 31, 2019, by and between the Registrant and Oxford Finance LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2019
Common Stock Sales Agreement, dated December 12, 2018, by and between Regulus Therapeutics Inc. and H.C. Wainwright & Co., LLC
Stock Agreements
Regulus Therapeutics Inc.
Biotechnology
NY
2018
Form of common stock certificate of the Registrant
Stock Agreements
Regulus Therapeutics Inc.
Biotechnology
2018
Second Amendment to Loan and Security Agreement, dated March 6, 2018, by and between the Registrant and Oxford Finance LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2018
First Amendment to Loan and Security Agreement, dated October 4, 2017, by and between the Registrant and Oxford Finance LLC
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
2018
RELEASE AND WAIVER OF CLAIMS
Release Agreements
Regulus Therapeutics Inc.
Biotechnology
CA
2017
44,000,000Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Regulus Therapeutics Inc.
Biotechnology
NY
2017
LOAN AND SECURITY AGREEMENT
Loan Agreements
Regulus Therapeutics Inc.
Biotechnology
CA
2016
5,294,118 Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Regulus Therapeutics Inc.
Biotechnology
NY
2014
[ ] Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Regulus Therapeutics Inc.
Biotechnology
NY
2013
CONVERTIBLE PROMISSORY NOTE
Note Agreements
Regulus Therapeutics Inc.
Biotechnology
2012
REGULUS THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT REGULUS THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Regulus Therapeutics Inc.
Biotechnology
CA
2012
REGULUS THERAPEUTICS INC. 2012 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 7, 2012 APPROVED BY THESTOCKHOLDERS: SEPTEMBER 7, 2012
Stock Agreements
Regulus Therapeutics Inc.
Biotechnology
2012
REGULUS THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT REGULUS THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Regulus Therapeutics Inc.
Biotechnology
CA
2012
AMENDMENT NUMBER TWO TO THE FOUNDING INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Regulus Therapeutics Inc.
Biotechnology
2012
AMENDMENT NUMBER ONE TO THE FOUNDING INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Regulus Therapeutics Inc.
Biotechnology
2012
REGULUS THERAPEUTICS INC. FOUNDING INVESTOR RIGHTS AGREEMENT REGULUS THERAPEUTICS INC. FOUNDING INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Regulus Therapeutics Inc.
Biotechnology
DE
2012
REGULUS THERAPEUTICS INC. 2012 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 8, 2012 APPROVED BY THESTOCKHOLDERS: , 2012
Stock Agreements
Regulus Therapeutics Inc.
Biotechnology
2012
[ ] Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Regulus Therapeutics Inc.
Biotechnology
NY
2012